ARRY

Array BioPharma Inc. News Headlines

$4
*  
0.24
5.66%
Get ARRY Alerts
*Delayed - data as of Jul. 31, 2014  -  Find a broker to begin trading ARRY now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Pharmacyclics to Sell Shares - Analyst Blog
3/11/2013 5:00:01 PM - Zacks.com

Santarus Tops, Focus on Zegerid - Analyst Blog
3/11/2013 2:09:49 PM - Zacks.com

Good News for Gilead's HIV Pipeline - Analyst Blog
3/7/2013 2:40:01 PM - Zacks.com

Nektar Loss Widens, Gives Guidance - Analyst Blog
3/7/2013 1:41:01 PM - Zacks.com

Vertex Flu Drug Shows Promise - Analyst Blog
3/6/2013 1:20:01 PM - Zacks.com

Regeneron to Earn More Royalty - Analyst Blog
3/5/2013 2:40:01 PM - Zacks.com

JAZZ Beats EPS, Misses Sales - Analyst Blog
3/5/2013 2:19:01 PM - Zacks.com

Loss at Dynavax Wider than Expected - Analyst Blog
3/5/2013 2:17:01 PM - Zacks.com

Celgene's Apremilast Encourages - Analyst Blog
3/4/2013 2:30:01 PM - Zacks.com

Encouraging News for Cubist Pharma - Analyst Blog
3/1/2013 6:00:01 PM - Zacks.com

Idenix Reports In-Line 4Q Loss - Analyst Blog
3/1/2013 11:08:01 AM - Zacks.com

Medivation Beats 4Q Expectations - Analyst Blog
3/1/2013 10:00:01 AM - Zacks.com

Cubist Pharma Inks Deal - Analyst Blog
2/26/2013 6:25:01 PM - Zacks.com

Celgene Plans $600M Share Buyback - Analyst Blog
2/21/2013 5:50:01 PM - Zacks.com

Gilead and Teva Bury the Hatchet - Analyst Blog
2/21/2013 2:30:01 PM - Zacks.com

Savient to Promote Sobi's Kineret - Analyst Blog
2/21/2013 12:50:01 PM - Zacks.com

Gilead Presents Positive HCV Data - Analyst Blog
2/20/2013 2:30:01 PM - Zacks.com

Pipeline Progress at Bayer/Regeneron - Analyst Blog
2/19/2013 6:15:01 PM - Zacks.com

Eylea Drives Regeneron - Analyst Blog
2/15/2013 3:32:01 PM - Zacks.com

Alexion 4Q Tops on Both Lines - Analyst Blog
2/14/2013 4:09:01 PM - Zacks.com

Zacks Rank #1 Addition for Tuesday - Tale of the Tape
2/12/2013 9:44:01 AM - Zacks.com

Synta: Share Price Not Reflecting Ganetespib Value Proposition
1/15/2013 12:09:00 PM - Seeking Alpha

Biotech Portfolio Update: 2012 Summary And 2013 Outlook
12/24/2012 7:24:00 AM - Seeking Alpha

Is Telik A Good Buy After Increasing 24% In One Day?
12/12/2012 4:16:00 PM - Seeking Alpha

What Is So Exciting About MEI Pharma?
11/16/2012 3:43:00 PM - Seeking Alpha